Mohamad Mohty is Professor of hematology and head of the hematology and cellular therapy Department at the Saint-Antoine Hospital and Sorbonne University (Paris, France). Professor Mohty is also head of a translational research team (INSERM team) at the Saint-Antoine Research center in Paris and his research is focused on the pathophysiology and immunobiology of normal and pathological antigen-presenting cells, especially the impact of novel immunomodulatory agents such as proteasome inhibitors, IMiDs and hypomethylating agents.
He has a special clinical focus on the development of reduced-toxicity conditioning regimens, immunotherapy and different aspects of therapy of acute leukemia and multiple myeloma.
Professor Mohty is past-president of the European Society for Blood and Marrow Transplantation (EBMT), and the current chairman of the Acute Leukemia Working Party of EBMT. He is also co-founder and chairman of the “International Academy for Clinical Hematology (IACH; http://clinical-hematology.org/).
Professor Mohty has published more than 600 peer-reviewed articles (https://www.ncbi.nlm.nih.gov/pubmed/?term=MOHTY+M) in the field of stem cell transplantation, leukemia and myeloma, in different hematology and immunology journals. He also serves as Editor-in-Chief of the journal Bone Marrow Transplantation, as Associate Editor for Leukemia, European Journal of Haematology and Blood Cancer Journal, and as member of the editorial board of Haematologica.